Nobilis Health Corp. (NRTSF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 5, 2026

Nobilis Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Jun '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13
Operating Revenue
272.53288.05277.9421983.0931.13
Other Revenue
10.069.278.196.660.94-
282.58297.32286.13225.6684.0331.13
Revenue Growth (YoY)
-12.04%3.91%26.80%168.55%169.95%50.00%
Cost of Revenue
109.45112.69109.7978.2123.234.42
Gross Profit
173.13184.63176.34147.4560.826.71
Selling, General & Admin
136.17150.42157.17111.1138.6921.3
Amortization of Goodwill & Intangibles
-----0.73
Other Operating Expenses
-----0.18
Operating Expenses
152.47162.02166.01115.840.3122.21
Operating Income
20.6622.6110.3431.6520.494.5
Interest Expense
-9.57-6.01-4-1.6-0.29-
Earnings From Equity Investments
-0.11-0.110.94---
Other Non Operating Income (Expenses)
7.245.094.618.95-3.75-0
EBT Excluding Unusual Items
18.2221.5811.893916.454.5
Merger & Restructuring Charges
-0.3-0.3-0.3---
Impairment of Goodwill
---1.73-2.39
Gain (Loss) on Sale of Assets
-----0
Asset Writedown
-1.5-1.5----
Legal Settlements
3.53.5----
Pretax Income
19.9223.2811.5940.7416.456.89
Income Tax Expense
12.09134.49-23.20.48-
Earnings From Continuing Operations
7.8310.287.163.9315.976.89
Minority Interest in Earnings
-6.19-6.48-0.65-13.09-13.08-5.48
Net Income
1.643.86.4550.842.891.42
Net Income to Common
1.643.86.4550.842.891.42
Net Income Growth
-71.65%-41.12%-87.31%1657.35%104.31%18.10%
Shares Outstanding (Basic)
787876674737
Shares Outstanding (Diluted)
787878754838
Shares Change (YoY)
-0.25%0.81%3.10%57.65%26.79%5.24%
EPS (Basic)
0.020.050.080.760.060.04
EPS (Diluted)
0.020.050.080.680.060.04
EPS Growth
-72.00%-39.04%-88.23%1033.35%55.91%28.28%
Free Cash Flow
7.5421.24-3.972.341.982.31
Free Cash Flow Per Share
0.100.27-0.050.030.040.06
Gross Margin
61.27%62.10%61.63%65.34%72.36%85.79%
Operating Margin
7.31%7.60%3.61%14.03%24.39%14.45%
Profit Margin
0.58%1.28%2.25%22.53%3.44%4.55%
Free Cash Flow Margin
2.67%7.14%-1.39%1.03%2.35%7.41%
EBITDA
36.9634.2119.1736.3422.115.23
EBITDA Margin
13.08%11.51%6.70%16.10%26.31%16.80%
D&A For EBITDA
16.3111.68.834.691.620.73
EBIT
20.6622.6110.3431.6520.494.5
EBIT Margin
7.31%7.60%3.61%14.03%24.39%14.45%
Effective Tax Rate
60.70%55.84%38.72%-2.92%-
Revenue as Reported
284.99299.72285.74229.2284.0331.13
Advertising Expenses
-37.443.835-3.2
Source: S&P Global Market Intelligence. Standard template. Financial Sources.